Know Cancer

or
forgot password

Genetic Predictive Model Based on Single Nucleotide Polymorphisms in the DNA Repair Pathway and Drug Metabolis/Transport Pharmacogenetics in the Prediction of Response and Treatment Outcomes in Acute Myeloid Leukemia


N/A
15 Years
N/A
Open (Enrolling)
Both
Patients With Acute Myeloid Leukemia, Patients Receiving Induction/Consolidation Chemotherapy

Thank you

Trial Information

Genetic Predictive Model Based on Single Nucleotide Polymorphisms in the DNA Repair Pathway and Drug Metabolis/Transport Pharmacogenetics in the Prediction of Response and Treatment Outcomes in Acute Myeloid Leukemia


Inclusion Criteria:



- patients with acute myeloid leukemia

- 15 years or older

- patients treated with induction/consolidation chemotherapy

- patients with available bone marrow sample

Exclusion Criteria:

- acute biphenotypic leukemia

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Principal Investigator

Dong Hwan Kim, M.D., Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Samsung Medical Center

Authority:

South Korea: Institutional Review Board

Study ID:

2008-08-094

NCT ID:

NCT01106144

Start Date:

May 2010

Completion Date:

Related Keywords:

  • Patients With Acute Myeloid Leukemia
  • Patients Receiving Induction/Consolidation Chemotherapy
  • Leukemia
  • Leukemia, Myeloid, Acute
  • Leukemia, Myeloid

Name

Location